Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

MDA-MB-361 breast adenocarcinoma cells treated in vitro with allosteric AKT inhibitor MK2206 until development of resistance.


ABSTRACT: Whole exome sequencing to determine whether acquisition of resistance to MK2206 in MDA-MB-361 is mediated by a new AKT1 mutation. Cells were exposed in vitro to drug for 12 weeks. Surviving cells were expanded for another 2 weeks in the presence of drug before sequencing.

INSTRUMENT(S): HiSeq X Ten

ORGANISM(S): Homo sapiens

SUBMITTER: NICOLAOS PALASKAS 

PROVIDER: E-MTAB-8066 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2015-01-22 | E-GEOD-63420 | biostudies-arrayexpress
2018-12-05 | PXD007662 | Pride
2015-01-19 | E-GEOD-62907 | biostudies-arrayexpress
2016-04-27 | E-MTAB-4181 | biostudies-arrayexpress
2016-01-08 | E-GEOD-76207 | biostudies-arrayexpress
2018-12-29 | E-MTAB-6619 | biostudies-arrayexpress
2020-03-01 | E-MTAB-7760 | biostudies-arrayexpress
2023-09-06 | E-MTAB-13338 | biostudies-arrayexpress
2018-03-31 | E-MTAB-4663 | biostudies-arrayexpress
2023-09-01 | E-MTAB-13216 | biostudies-arrayexpress